AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 67 filers reported holding AXSOME THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.52 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $5,248,000 | +903.4% | 259,310 | +1176.8% | 1.69% | +1241.3% |
Q2 2019 | $523,000 | -13.3% | 20,310 | -52.1% | 0.13% | -22.7% |
Q1 2019 | $603,000 | -43.9% | 42,410 | -88.9% | 0.16% | -58.3% |
Q4 2018 | $1,074,000 | -25.3% | 380,812 | -8.6% | 0.39% | -20.7% |
Q3 2018 | $1,437,000 | +132.1% | 416,458 | +115.5% | 0.49% | +44.2% |
Q2 2018 | $619,000 | +30.6% | 193,290 | 0.0% | 0.34% | +20.0% |
Q1 2018 | $474,000 | -46.1% | 193,290 | +20.8% | 0.28% | -31.8% |
Q2 2017 | $880,000 | +7.4% | 160,000 | -23.8% | 0.42% | -8.7% |
Q1 2017 | $819,000 | – | 210,000 | – | 0.46% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ALETHEA CAPITAL MANAGEMENT, LLC | 1,132,645 | $37,332,000 | 32.86% |
MORGAN JESS S & CO INC | 113,430 | $3,739,000 | 2.47% |
Fairmount Funds Management LLC | 187,598 | $6,183,000 | 2.25% |
IRIDIAN ASSET MANAGEMENT LLC/CT | 1,423,653 | $46,924,000 | 1.43% |
WMS Partners, LLC | 250,000 | $8,240,000 | 1.21% |
Beck Bode, LLC | 102,127 | $3,366,000 | 0.94% |
RTW INVESTMENTS, LP | 1,616,497 | $53,280,000 | 0.80% |
MPM BioImpact LLC | 110,155 | $3,631,000 | 0.56% |
Endurant Capital Management LP | 52,048 | $1,716,000 | 0.39% |
Bellevue Group AG | 752,945 | $24,817,000 | 0.25% |